4.59
前日終値:
$4.49
開ける:
$4.5
24時間の取引高:
4.21M
Relative Volume:
1.32
時価総額:
$1.41B
収益:
$248.37M
当期純損益:
$11.74M
株価収益率:
91.80
EPS:
0.05
ネットキャッシュフロー:
$18.24M
1週間 パフォーマンス:
+11.68%
1か月 パフォーマンス:
+20.16%
6か月 パフォーマンス:
-12.24%
1年 パフォーマンス:
-27.49%
Mannkind Corp Stock (MNKD) Company Profile
MNKD を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MNKD
Mannkind Corp
|
4.59 | 1.38B | 248.37M | 11.74M | 18.24M | 0.05 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-16 | 再開されました | H.C. Wainwright | Buy |
2025-04-10 | 開始されました | Mizuho | Outperform |
2025-02-10 | 開始されました | Wedbush | Outperform |
2024-12-20 | 開始されました | Wells Fargo | Overweight |
2024-12-19 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
2024-09-09 | 再開されました | Leerink Partners | Outperform |
2024-06-13 | 開始されました | Rodman & Renshaw | Buy |
2023-10-10 | 開始されました | Wedbush | Outperform |
2021-05-14 | 開始されました | RBC Capital Mkts | Sector Perform |
2019-12-24 | 開始されました | Oppenheimer | Outperform |
2019-10-25 | 開始されました | Cantor Fitzgerald | Overweight |
2019-05-14 | 開始されました | BTIG Research | Buy |
2019-03-04 | 開始されました | SVB Leerink | Outperform |
2019-02-22 | 開始されました | SVB Leerink | Outperform |
2018-02-28 | ダウングレード | Maxim Group | Hold → Sell |
2017-11-01 | ダウングレード | Maxim Group | Buy → Hold |
2017-10-10 | 開始されました | H.C. Wainwright | Buy |
2017-10-06 | 繰り返されました | Maxim Group | Buy |
2017-08-11 | 開始されました | Maxim Group | Buy |
2016-05-10 | 繰り返されました | Piper Jaffray | Underweight |
2016-05-10 | 繰り返されました | RBC Capital Mkts | Underperform |
2016-01-06 | 繰り返されました | Piper Jaffray | Underweight |
2016-01-06 | 繰り返されました | RBC Capital Mkts | Underperform |
2015-11-04 | ダウングレード | RBC Capital Mkts | Outperform → Underperform |
2015-09-09 | ダウングレード | Piper Jaffray | Neutral → Underweight |
2015-08-03 | 繰り返されました | RBC Capital Mkts | Outperform |
2015-05-11 | ダウングレード | JP Morgan | Neutral → Underweight |
2015-05-11 | 繰り返されました | MLV & Co | Hold |
2015-04-16 | 繰り返されました | RBC Capital Mkts | Outperform |
すべてを表示
Mannkind Corp (MNKD) 最新ニュース
How MannKind Corporation stock performs during market volatilityTrade Exit Summary & Risk Controlled Stock Alerts - Newser
Trend analysis for MannKind Corporation this week2025 Big Picture & Fast Gain Swing Alerts - Newser
How to recover losses in MannKind Corporation stockWall Street Watch & Verified Technical Signals - Newser
Historical volatility pattern of MannKind Corporation visualizedEarnings Growth Report & Smart Investment Allocation Tips - Newser
Can trapped investors hope for a rebound in MannKind Corporation2025 Earnings Surprises & Technical Pattern Recognition Alerts - Newser
Applying chart zones and confluence areas to MannKind CorporationInflation Watch & Safe Entry Point Identification - Newser
Forecasting MannKind Corporation price range with options dataWeekly Risk Report & High Conviction Trade Alerts - Newser
What to expect from MannKind Corporation in the next 30 days2025 Major Catalysts & High Yield Equity Trading Tips - Newser
Published on: 2025-08-31 07:53:49 - Newser
When is the best time to exit MannKind CorporationMarket Sentiment Summary & Safe Entry Zone Tips - Newser
How to integrate MannKind Corporation into portfolio analysis toolsPortfolio Return Summary & Real-Time Buy Signal Notifications - Newser
Applying sector rotation models to MannKind CorporationWeekly Investment Report & Weekly High Conviction Ideas - Newser
MannKind Corporation stock trend forecastJuly 2025 Outlook & AI Enhanced Trading Signals - Newser
Published on: 2025-08-30 22:04:25 - Newser
Is now a turning point for MannKind Corporation2025 Short Interest & Risk Adjusted Buy and Sell Alerts - Newser
Full technical analysis of MannKind Corporation stockMarket Activity Report & Weekly Return Optimization Plans - Newser
Using fundamentals and technicals on MannKind CorporationVolume Spike & AI Driven Stock Reports - Newser
Does MannKind Corporation show high probability of reboundQuarterly Trade Report & Fast Moving Stock Watchlists - Newser
MannKind Buys scPharmaceuticals For $360 Million Bet: Can This Transform Its Future In Cardiorenal Care? - Smartkarma
Has MannKind Corporation formed a bullish divergence2025 Technical Patterns & AI Driven Price Predictions - Newser
Is MannKind Corporation stock reversal real or fakeWeekly Risk Report & Verified Entry Point Signals - Newser
Does MannKind Corporation fit your quant trading model2025 Price Action Summary & Reliable Price Breakout Alerts - Newser
MannKind to acquire scPharmaceuticals stock in $303 million deal, H.C. Wainwright downgrades - Investing.com
MannKind Corporation (MNKD) Seeks FDA Pediatric Approval for Afrezza - Insider Monkey
Mannkind Corp (MNKD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):